Mycobacterium avium complex infection in non‐cystic fibrosis bronchiectasis

Reliable markers of disease progression or stability to assist in management decisions are lacking in patients with non‐cystic fibrosis bronchiectasis and Mycobacterium avium complex (MAC) infection.

[1]  K. Winthrop,et al.  Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[3]  D. Denning,et al.  Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  F. Drobniewski.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999 , 2000, Thorax.

[5]  Pan‐Chyr Yang,et al.  Increasing Incidence of Nontuberculous Mycobacteria , 2010 .

[6]  R. Wilson,et al.  Non-tuberculous mycobacteria in patients with bronchiectasis , 2005, Thorax.

[7]  S. Muro,et al.  Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  Pan‐Chyr Yang,et al.  Increasing Incidence of Nontuberculous Mycobacteria, Taiwan, 2000–2008 , 2010, Emerging infectious diseases.

[9]  T. Kanauchi,et al.  Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. , 2012, American journal of respiratory and critical care medicine.

[10]  Young Kil Park,et al.  Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. , 2006, Chest.

[11]  K. Matsuura,et al.  Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  K. Winthrop,et al.  Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. , 2010, American journal of respiratory and critical care medicine.

[13]  Mary Ann Blosky,et al.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. , 2010, American journal of respiratory and critical care medicine.

[14]  R. Wilson,et al.  Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis , 2006, European Respiratory Journal.

[15]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[16]  M. Chung,et al.  High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. , 2008, AJR. American journal of roentgenology.

[17]  H. Sørensen,et al.  Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. , 2010, American journal of respiratory and critical care medicine.

[18]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[19]  H. Murray,et al.  A novel defect in interferon-gamma secretion in patients with refractory nontuberculous pulmonary mycobacteriosis. , 2003, Annals of internal medicine.

[20]  R. Stockley,et al.  Addition of salmeterol to existing treatment in patients with COPD: a 12 month study , 2006, Thorax.

[21]  Chong-Jen Yu,et al.  Clinical Characteristics and Prognosis of Nontuberculous Mycobacterial Lung Disease with Different Radiographic Patterns , 2011, Lung.

[22]  R. Chaiwarith,et al.  Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  R. Prescott,et al.  Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy , 2008, Thorax.